Pancreas Cancer: Now and the Era of Biomarker Directed Therapy

Eileen M. O’Reilly, MD

Winthrop Rockefeller Endowed Chair, Medical Oncology, Memorial Sloan Kettering; and Co-Director, Medical Initiatives, David M. Rubenstein Center

for Pancreatic Cancer     

The Role and Mechanism of Diabetes in Promoting Pancreatic Cancer

Stephen Pandol, MD

Professor, Medicine; and Director, Basic & Translational

Pancreas Research, Cedars-Sinai Medical Center                           

Targeting Adenosine Signaling to Enhance Immunotherapy

in Pancreatic Cancer

Timothy Donahue, MD

Professor, Surgery, David Geffen School of Medicine at UCLA     

Clonal Heterogeneity in Human Pancreatic Ductal Adenocarcinoma

and Its Impact on Tumor Progression

Diane Simeone, MD

Director, Moores Cancer Center, University of California, San Diego   

Logic Gated CAR-T Therapies in Pancreatic Cancer: New Approaches

for Screening and Treating Patients

Randy Hecht, MD

Professor, Clinical Medicine; and Director, Gastrointestinal Oncology

Program, David Geffen School of Medicine at UCLA      

Oncogenic KRAS-driven Regulation of the Tumor Microenvironment

Marina Pasca Di Magliano, PhD

Associate Professor, General Surgery,

University of Michigan Medical School              

Uncovering Metabolic Drivers of Tumor Progression and Metastasis

Rushika Perera, PhD

Professor, Anatomy, University of California, San Francisco      – and –

Obesity and Stress in Pancreatic Cancer

Guido Eibl, MD

Professor in Residence, Surgery, David Geffen School of Medicine at UCLA

RSVP is Required by September 30 – https://support.pancreatic.org/site/SPageServer/?pagename=scientific_symposium_register

Contact – Julie Hirschberg – julie@pancreatic.org

UCLA Faculty Club